BioMarin也迅速跟进迭代研发，其升级版在研产品BMN333同样旨在实现周剂注射。早期临床结果显示BMN333的AUC水平高于其他长效CNP研究的3倍以上，公司研发主管Greg Friberg表示该药对标的正是TransCon-CNP。
Раскрыты подробности о договорных матчах в российском футболе18:01
，推荐阅读爱思助手下载最新版本获取更多信息
4 points on a circle
Цены на нефть взлетели до максимума за полгода17:55
Some people might be overindexing on Anthropic's formal documents and structure, whereas, in reality, given their actual institutional structure and the separation of the Long-Term Benefit Trust (even if it were mission aligned) from its operational decisions, it is somewhat straightforward for Anthropic to do things regardless of the formal documents, including giving in to various pressures and incentives in order to stay at the frontier.